Search Results - "Stout, Gordon G."

Effect of Intranasal Mupirocin Prophylaxis on Methicillin-Resistant Staphylococcus aureus Transmission and Invasive Staphylococcal Infections in a Neonatal Intensive Care Unit by Ristagno, Elizabeth H, Bryant, Kristina A, Boland, Lynette F, Stout, Gordon G, Junkins, Alan D, Woods, Charles R, Myers, John A, Espinosa, Claudia M

“…The use of monthly intranasal mupirocin was associated with a significant reduction in the rate of methicillin-resistant Staphylococcus aureus transmission and…”
Get full text

Nasopharyngeal Colonization With Heptavalent Pneumococcal Conjugate Vaccine Serotypes of Streptococcus pneumoniae With Prolonged Vaccine Dosing Intervals by Jones, Veronnie Faye, Harrison, Christopher, Stout, Gordon G, Hopkins, Jennifer

“…INTRODUCTION:Universal infant heptavalent pneumococcal conjugate vaccine (PCV-7) immunization, dosed near to the originally recommended schedule of a 3-dose…”
Get full text

Cytomegalovirus seroprevalence among women of childbearing age during a 10-year period by Marshall, Gary S, Stout, Gordon G

“…The incidence of congenital cytomegalovirus (CMV) disease is dependent on the rate of virus acquisition by susceptible women in temporal proximity to…”
Get more information

Effect of rapid viral diagnosis on the management of children hospitalized with lower respiratory tract infection by ADCOCK, PENNY M, STOUT, GORDON G, HAUCK, MARY A, MARSHALL, GARY S

“…BACKGROUND.Although rapid viral tests are commonly used in children with lower respiratory tract infection, their effect on patient management has not been…”
Get full text

Antibodies to the major linear neutralizing domains of cytomegalovirus glycoprotein B among natural seropositives and CMV subunit vaccine recipients by Marshall, G S, Li, M, Stout, G G, Louthan, M V, Duliège, A M, Burke, R L, Hunt, L A

“…The gB protein (gpUL55) of human cytomegalovirus (CMV) contains C-terminal (AD-1) and N-terminal (AD-2) linear immunodominant neutralizing domains. To measure…”
Get more information

Processing of human cytomegalovirus glycoprotein B in recombinant adenovirus-infected cells by Marshall, Gary S, Fenger, Denice P, Stout, Gordon G, Knights, Mari E, Hunt, Lawrence A

“…1 Department of Pediatrics and 2 Department of Microbiology & Immunology, University of Louisville School of Medicine, Louisville, Kentucky 40292, USA…”
Get full text

Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States by Marshall, Gary S, Stout, Gordon G, Jacobs, Richard F, Schutze, Gordon E, Paxton, Helene, Buckingham, Steven C, DeVincenzo, John P, Jackson, Mary Anne, San Joaquin, Venusto H, Standaert, Steven M, Woods, Charles R

“…The reported annual incidence of Rocky Mountain spotted fever in the United States is 2.2 per million, but studies have suggested that human infection with…”
Get more information

Antibodies to Recombinant-Derived Glycoprotein B after Natural Human Cytomegalovirus Infection Correlate with Neutralizing Activity by Marshall, Gary S., Rabalais, Gerard P., Stout, Gordon G., Waldeyer, Sharon L.

“…Glycoprotein B (gB) of human cytomegalovirus (HCMV) was partially purified by lentil-lectin column chromatography from cells infected with an adenovirus-gB…”
Get full text

Ontogeny of glycoprotein gB-specific antibody and neutralizing activity during natural cytomegalovirus infection by Marshall, G S, Stout, G G, Knights, M E, Rabalais, G P, Ashley, R, Miller, H, Rossier, E

“…The envelope glycoprotein gB (gpUL55) is a candidate for inclusion in subunit cytomegalovirus (CMV) vaccines, although data on gB antibody responses after…”
Get more information